Indefinite Delivery Contract SPE2DX15D9959

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

DMS Pharmaceutical Group provides an extensive array of medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the diverse medical requirements of the Department of Defense (DoD) and Department of Veterans Affairs (VA). The products supplied range from common medications like antibiotics and pain relievers to specialized drugs such as oncology treatments and specialty pharmaceuticals. This IDC complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.